R&D
For a better future SCM Lifescience will do its best
Result
Number
Patent name
Application number
Application Date
Application country
31
Composition for preventing or treating diseases mediated to regulatory T cell
Application number
10201912046V
Application Date
2019.12.12
Application country
Filed(SG)
30
Method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof
Application number
2708987
Application Date
2019.12.12
Application country
Patent(RU)
29
Composition for preventing or treating diseases mediated to regulatory T cell
Application number
108699524
Application Date
2019.12.10
Application country
Patent(CN)
28
Composition for preventing or treating diseases mediated to regulatory T cell
Application number
10-2025417
Application Date
2019.09.19
Application country
Patent(KR)
27
Composition for preventing or treating diseases mediated to regulatory T cell
Application number
6580791
Application Date
2019.09.06
Application country
Patent(JP)
26
Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active
Application number
3281635
Application Date
2019.07.24
Application country
Patent(EP)
25
Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient
Application number
10-2000217
Application Date
2019.07.09
Application country
Patent(KR)
24
Method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof
Application number
10-1984227
Application Date
2019.05.24
Application country
Patent(KR)
23
Pharmaceutical composition for prevention or treatment of immune diseases and inflammatory diseases comprising immunogenic stimulated mesenchymal stem cells
Application number
17849104.9
Application Date
2019.04.04
Application country
Filed(EP)
22
Pharmaceutical composition for prevention or treatment of immune diseases and inflammatory diseases comprising immunogenic stimulated mesenchymal stem cells
Application number
16/331426
Application Date
2019.03.07
Application country
Filed(US)